Enveric Biosciences, Inc. Profile
Industry
BiotechnologySector
HealthcareNumber of Employees
7Enveric Biosciences's Business Model
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
About Enveric Biosciences
Website: https://www.enveric.com
CEO (Chief Executive Officer): Dr. Joseph Edward Tucker Ph.D.
IPO date: 2015-05-04
Contact
Country: US
Address: 4851 Tamiami Trail North
City: Naples
State: FL
Phone: 239 302 1707
Zip Code: 34103
Other
CIK: 0000890821
ISIN: US29405E2081
CUSIP: 29405E208
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
